查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1842161

伴侣动物心臟药物市场规模、份额和趋势分析报告：按产品类型、动物类型、适应症、最终用途、通路、地区和细分市场划分，预测期为2025-2033年

Companion Animal Cardiac Drugs Market Size, Share & Trends Analysis Report By Product (Pimobendan, Furosemide), By Animal Type (Dogs, Cats, Horses), By Indication, By End-use, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

伴侣动物心臟药物市场摘要

全球伴侣动物心臟药物市场预计在 2024 年达到 18.8 亿美元，预计到 2033 年将达到 37.3 亿美元，2025 年至 2033 年的复合年增长率为 8.13%。

该行业受到几个关键因素的推动，包括宠物心臟相关疾病的日益普遍、宠物的人性化以及宠物医疗保健支出的增加，以及心臟治疗技术的不断创新。

治疗方法的进步以及人们对动物心臟健康重要性的日益重视，促使宠物饲主寻求专业的医疗照护。宠物保险的日益普及在推动伴侣动物心臟药物市场成长方面发挥关键作用。像Frank和Trusted Insurance Services Ltd这样的保险公司提供各种保险计划，涵盖多种疾病，包括心臟病、癌症、关节炎、糖尿病、感染疾病和其他慢性病。此类保险减轻了宠物饲主的财务负担，使他们能够更有信心地选择先进的治疗方法并专注于长期护理。这种可负担性和可及性的提高，鼓励了更早的兽医干预和持续使用处方药物，从而扩大了患者群体，并推动了对心臟药物的持续需求。

此外，市场成长得益于临床、製药和公众意识主导等多面向倡议的共同推动。魁北克省和亚伯达等省份的兽医学院与私人诊所之间的合作，促进了最新心臟病治疗通讯协定的推广应用，使兽医能够更有效地诊断和治疗心臟病。这直接增加了对心臟病药物的需求，因为更多伴侣动物能够及时接受治疗。同时，勃林格殷格翰和硕腾加拿大等製药公司加强了在各省的分销网络，确保能够持续获得先进药物。药物供应的增加增强了兽医开立这些药物的信心，缩小了治疗差距，并改善了慢性心臟疾病的长期管理。

同时，由加拿大爱护动物协会（Humane Canada）和加拿大兽医协会（CVMA）等机构主导的宣传宣传活动在教育饲主了解心臟病早期预警信号（例如持续咳嗽和体力下降）方面发挥关键作用。这些努力促使宠物主人更早就医并及时开始治疗，进一步增加了接受治疗的患者数量。临床通讯协定的改进、强大的药品分销体係以及公众意识的提高，正在推动市场稳步成长，尤其是在ACE抑制剂、利尿剂和β阻断剂关键药物类别方面。

此外，随着全球对专业动物医疗保健的需求持续增长，监管核准在兽医循环系统市场的重要性日益凸显。过去，缓慢且限制重重的核准流程阻碍了创新治疗方法和医疗设备的引入，但美国FDA、欧洲药品管理局（EMA）和印度CDSCO等监管机构正开始采取更精简的审批方式，以确保患者能够更快地获得先进的兽医解决方案。

例如，2024年5月，FDA核准了多种动物用药品，其中包括用于治疗犬心臟衰竭的药物。值得注意的是，托拉塞米口服溶液Upcard-CA1获得了有条件核准，用于治疗因粘液瘤性二尖瓣疾病（MMVD）引起的郁血性心臟衰竭犬的肺水肿。这项核准代表了兽医循环系统领域的一项重大进展，它拓展了治疗选择，并改善了犬心臟病的治疗效果，尤其是在与匹莫苯丹、Spiranolactone和ACE抑制剂等现有疗法联合使用时。

目录

第一章调查方法和范围

第二章执行摘要

第三章：伴侣动物心臟病药物市场趋势与展望

  • 市场体系展望
    • 母市场
    • 子公司市场
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 伴侣动物心臟病药物市场分析工具
    • 产业分析—波特五力分析
    • PESTEL 分析
    • 法律规范
    • 定价分析
    • 各国主要动物物种数量估计（2024 年）

第四章 伴侣动物心臟药物市场：依动物类型分類的估算与趋势分析

  • 细分仪表板
  • 伴侣动物心臟病药物市场：按动物类型分類的差异分析
  • 伴侣动物心臟病药物市场规模及趋势分析（依动物类型划分，2021-2033年）
  • 狗
  • 猫
  • 马
  • 其他的

第五章 伴侣动物心臟药物市场：依产品分類的估算与趋势分析

  • 细分仪表板
  • 伴侣动物心臟病药物市场：按产品分類的差异分析
  • 伴侣动物心臟病药物市场规模及产品趋势分析（2021-2033年）
  • 皮莫本丹
  • Spiranolactone和盐酸Benazepril那普利
  • Furosemide
  • 其他的

第六章：伴侣动物心臟药物市场：依适应症分類的估算与趋势分析

  • 细分仪表板
  • 伴侣动物心臟药物市场：依适应症分析变化
  • 伴侣动物心臟药物市场规模及趋势分析（依适应症划分，2021-2033年）
  • 郁血性心臟衰竭衰竭
  • 心肌病变
  • 心律不整
  • 其他的

7. 伴侣动物心臟药物市场：依最终用途分類的估算与趋势分析

  • 细分仪表板
  • 伴侣动物心臟病药物市场：按最终用途分類的差异分析
  • 伴侣动物心臟病药物市场规模及趋势分析（按最终用途划分），2021-2033年
    • 兽医医院和诊所
    • 其他的

8. 伴侣动物心臟病药物市场：按分销管道分類的估算和趋势分析

  • 细分仪表板
  • 伴侣动物心臟病药物市场：通路变化分析
  • 伴侣动物心臟病药物市场规模及趋势分析（依通路划分，2021-2033年）
    • 医院/诊所药房
    • 零售
    • 电子商务

9. 伴侣动物心臟病药物市场：区域估算与趋势分析

  • 区域仪錶板
  • 2024 年及 2033 年各地区伴侣动物心臟病药物市场份额
  • 区域展望
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特
    • 卡达
    • 阿曼

第十章 竞争格局

  • 市场参与企业分类
  • 企业市场分析/堆图分析
  • 公司简介
    • Boehringer Ingelheim International GmbH
    • Elanco
    • Ceva
    • Merck &Co., Inc.
    • Virbac
    • Zoetis
    • Dechra
    • Bimeda Corporate
    • Biogenesis Bago
    • Vetoquinol SA
  • 策略倡议
  • 其他主要企业名单
Product Code: GVR-4-68040-723-9

Companion Animal Cardiac Drugs Market Summary

The global companion animal cardiac drugs market size was estimated at USD 1.88 billion in 2024 and is projected to reach USD 3.73 billion by 2033, growing at a CAGR of 8.13% from 2025 to 2033. The industry is driven by several key factors, including the rising prevalence of heart-related disorders in pets, increasing pet humanization and expenditure on pet healthcare, and continuous innovation in cardiology treatments.

Advancements in therapies and growing awareness about the importance of cardiac health in animals are encouraging pet owners to pursue specialized care. The rising penetration of pet insurance is playing a crucial role in driving the growth of the companion animal cardiac drugs market. Providers such as Frank and Trusted Insurance Services Ltd offer diverse insurance plans that cover a broad spectrum of illnesses, including heart disease, cancer, arthritis, diabetes, infections, and other chronic conditions. Such coverage eases the financial strain on pet owners, enabling them to opt for advanced treatments and commit to long-term therapies without hesitation. This increased affordability and access encourage earlier veterinary intervention and consistent use of prescribed medications, thereby expanding the treated patient pool and fueling sustained demand for cardiac drugs.

Moreover, the market growth is accelerated by a combination of clinical, pharmaceutical, and awareness-driven initiatives. Collaborations between veterinary schools and private clinics in provinces such as Quebec and Alberta have facilitated the dissemination of updated cardiac care protocols, enabling veterinarians to diagnose and manage heart conditions more effectively. This has expanded the number of companion animals receiving timely treatment, directly increasing the demand for cardiac drugs. In parallel, pharmaceutical firms like Boehringer Ingelheim and Zoetis Canada have strengthened their provincial distribution networks, ensuring consistent availability of advanced medications. Reliable access encourages veterinarians to prescribe therapies with greater confidence, reducing treatment gaps and improving long-term management of chronic cardiac conditions.

At the same time, awareness campaigns led by organizations such as Humane Canada and the Canadian Veterinary Medical Association (CVMA) have played a crucial role in educating pet owners about early warning signs of heart disease, such as persistent coughing or reduced stamina. These initiatives prompt earlier veterinary consultations and timely initiation of treatment, further enlarging the treated patient pool. Collectively, improved clinical protocols, strong drug distribution infrastructure, and greater public awareness are fueling steady market growth, particularly in key drug categories like ACE inhibitors, diuretics, and beta-blockers.

Furthermore, regulatory approval is becoming increasingly important in the veterinary cardiology market as global demand for specialized animal care continues to grow. In the past, slow and restrictive approval processes limited the adoption of innovative treatments and medical devices, but regulatory agencies such as the U.S. FDA, the European Medicines Agency (EMA), and India's CDSCO have started to adopt more facilitative approaches to ensure faster access to advanced veterinary solutions.

For instance, in May 2024, the FDA approved several animal drugs, including therapies for canine heart failure. Notably, UpCard-CA1, a torsemide oral solution, received conditional approval for treating pulmonary edema in dogs with congestive heart failure caused by myxomatous mitral valve disease (MMVD). Used in combination with established therapies such as pimobendan, spironolactone, and ACE inhibitors, this approval represents a significant advancement in veterinary cardiology by expanding treatment options and improving the management of cardiac conditions in dogs.

Global Companion Animal Cardiac Drugs Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global companion animal cardiac drugs market report based on animal type, product, indication, end-use, distribution channel, and region.

  • Animal Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Dogs
  • Cats
  • Horses
  • Others
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Pimobendan
  • Spironolactone and benazepril hydrochloride
  • Furosemide
  • Others
  • Indication Outlook (Revenue, USD Million, 2021 - 2033)
  • Congestive Heart Failure
  • Myocardial (Heart Muscle) Disease
  • Arrhythmias
  • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Veterinary Hospitals & Clinics
  • Others
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospital/ Clinic Pharmacy
  • Retail
  • E-Commerce
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • India
    • China
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
    • Qatar
    • Oman

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
  • 1.4. Information/Data Analysis
  • 1.5. Market Formulation & Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis
    • 1.7.2. Global Market: CAGR Calculation
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Companion animal cardiac drugs market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market
    • 3.1.2. Ancillary Market
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising Prevalence Of Cardiac Diseases In Animals
      • 3.2.1.2. Increasing Animal Health Expenditure
      • 3.2.1.3. Rising Surgical Procedures
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Stringent regulations
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Companion animal cardiac drugs market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitution
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
    • 3.3.3. Regulatory Framework
    • 3.3.4. Pricing Analysis
    • 3.3.5. Estimated Animal Population by key species, key countries, 2024

Chapter 4. Companion animal cardiac drugs Market: Animal Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Companion animal cardiac drugs Market: Animal Type Movement Analysis
  • 4.3. Companion animal cardiac drugs market Size & Trend Analysis, by Animal Type, 2021 to 2033 (USD Million)
  • 4.4. Dogs
    • 4.4.1. Dogs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Cats
    • 4.5.1. Cats Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Horses
    • 4.6.1. Horses Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Companion Animal Cardiac Drugs Market: Product Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Companion animal cardiac drugs Market: Product Movement Analysis
  • 5.3. Companion animal cardiac drugs market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 5.4. Pimobendan
    • 5.4.1. Pimobendan Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. spironolactone and benazepril hydrochloride
    • 5.5.1. spironolactone and benazepril hydrochloride Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Furosemide
    • 5.6.1. Furosemide Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Companion Animal Cardiac Drugs Market: Indication Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Companion animal cardiac drugs Market: Indication Movement Analysis
  • 6.3. Companion animal cardiac drugs market Size & Trend Analysis, by Indication, 2021 to 2033 (USD Million)
  • 6.4. Congestive Heart Failure
    • 6.4.1. Congestive Heart Failure Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Myocardial (Heart Muscle) Disease
    • 6.5.1. Myocardial (Heart Muscle) Disease Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Arrhythmias
    • 6.6.1. Arrhythmias Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Companion animal cardiac drugs Market: By End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Companion animal cardiac drugs Market: By End Use Movement Analysis
  • 7.3. Companion animal cardiac drugs market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
    • 7.3.1. Veterinary Hospitals & Clinics
      • 7.3.1.1. Veterinary Hospitals & Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. Others
      • 7.3.2.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Companion animal cardiac drugs Market: By Distribution Channel Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Companion animal cardiac drugs Market: By Distribution Channel Movement Analysis
  • 8.3. Companion animal cardiac drugs market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
    • 8.3.1. Hospitals/Clinic pharmacy
      • 8.3.1.1. Hospitals/Clinic pharmacy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. Retail
      • 8.3.2.1. Retail Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. E-Commerce
      • 8.3.3.1. E-Commerce Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Companion animal cardiac drugs Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Dashboard
  • 9.2. Companion animal cardiac drugs market Share, By Region, 2024 & 2033, USD Million
  • 9.3. Regional Outlook
  • 9.4. North America
    • 9.4.1. North America Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.4.2. U.S.
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Competitive Scenario
      • 9.4.2.3. U.S. Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.4.3. Canada
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Competitive Scenario
      • 9.4.3.3. Canada Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.4.4. Mexico
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Competitive Scenario
      • 9.4.4.3. Mexico Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 9.5. Europe
    • 9.5.1. Europe Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.5.2. UK
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Competitive Scenario
      • 9.5.2.3. UK Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.5.3. Germany
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Competitive Scenario
      • 9.5.3.3. Germany Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.5.4. France
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Competitive Scenario
      • 9.5.4.3. France Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.5.5. Italy
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Competitive Scenario
      • 9.5.5.3. Italy Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.5.6. Spain
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Competitive Scenario
      • 9.5.6.3. Spain Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.5.7. Denmark
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Competitive Scenario
      • 9.5.7.3. Denmark Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.5.8. Sweden
      • 9.5.8.1. Key Country Dynamics
      • 9.5.8.2. Competitive Scenario
      • 9.5.8.3. Sweden Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.5.9. Norway
      • 9.5.9.1. Key Country Dynamics
      • 9.5.9.2. Competitive Scenario
      • 9.5.9.3. Norway Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 9.6. Asia Pacific
    • 9.6.1. Asia Pacific Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.6.2. Japan
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Competitive Scenario
      • 9.6.2.3. Japan Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.6.3. China
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Competitive Scenario
      • 9.6.3.3. China Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.6.4. India
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Competitive Scenario
      • 9.6.4.3. India Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.6.5. Australia
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Competitive Scenario
      • 9.6.5.3. Australia Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.6.6. South Korea
      • 9.6.6.1. Key Country Dynamics
      • 9.6.6.2. Competitive Scenario
      • 9.6.6.3. South Korea Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.6.7. Thailand
      • 9.6.7.1. Key Country Dynamics
      • 9.6.7.2. Competitive Scenario
      • 9.6.7.3. Thailand Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 9.7. Latin America
    • 9.7.1. Latin America Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.7.2. Brazil
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Competitive Scenario
      • 9.7.2.3. Brazil Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.7.3. Argentina
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Competitive Scenario
      • 9.7.3.3. Argentina Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 9.8. Middle East & Africa
    • 9.8.1. Middle East & Africa Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.8.2. South Africa
      • 9.8.2.1. Key Country Dynamics
      • 9.8.2.2. Competitive Scenario
      • 9.8.2.3. South Africa Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.8.3. Saudi Arabia
      • 9.8.3.1. Key Country Dynamics
      • 9.8.3.2. Competitive Scenario
      • 9.8.3.3. Saudi Arabia Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.8.4. UAE
      • 9.8.4.1. Key Country Dynamics
      • 9.8.4.2. Competitive Scenario
      • 9.8.4.3. UAE Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.8.5. Kuwait
      • 9.8.5.1. Key Country Dynamics
      • 9.8.5.2. Competitive Scenario
      • 9.8.5.3. Kuwait Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.8.6. Qatar
      • 9.8.6.1. Key Country Dynamics
      • 9.8.6.2. Competitive Scenario
      • 9.8.6.3. Kuwait Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 9.8.7. Oman
      • 9.8.7.1. Key Country Dynamics
      • 9.8.7.2. Competitive Scenario
      • 9.8.7.3. Kuwait Companion animal cardiac drugs market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Market Participant Categorization
  • 10.2. Company Market Position Analysis/ Heap Map Analysis
  • 10.3. Company Profiles
    • 10.3.1. Boehringer Ingelheim International GmbH
      • 10.3.1.1. Company overview
      • 10.3.1.2. Financial performance
      • 10.3.1.3. Product benchmarking
      • 10.3.1.4. Strategic initiatives
    • 10.3.2. Elanco
      • 10.3.2.1. Company overview
      • 10.3.2.2. Financial performance
      • 10.3.2.3. Product benchmarking
      • 10.3.2.4. Strategic initiatives
    • 10.3.3. Ceva
      • 10.3.3.1. Company overview
      • 10.3.3.2. Financial performance
      • 10.3.3.3. Product benchmarking
      • 10.3.3.4. Strategic initiatives
    • 10.3.4. Merck & Co., Inc.
      • 10.3.4.1. Company overview
      • 10.3.4.2. Financial performance
      • 10.3.4.3. Product benchmarking
      • 10.3.4.4. Strategic initiatives
    • 10.3.5. Virbac
      • 10.3.5.1. Company overview
      • 10.3.5.2. Financial performance
      • 10.3.5.3. Product benchmarking
      • 10.3.5.4. Strategic initiatives
    • 10.3.6. Zoetis
      • 10.3.6.1. Company overview
      • 10.3.6.2. Financial performance
      • 10.3.6.3. Product benchmarking
      • 10.3.6.4. Strategic initiatives
    • 10.3.7. Dechra
      • 10.3.7.1. Company overview
      • 10.3.7.2. Financial performance
      • 10.3.7.3. Product benchmarking
      • 10.3.7.4. Strategic initiatives
    • 10.3.8. Bimeda Corporate
      • 10.3.8.1. Company overview
      • 10.3.8.2. Financial performance
      • 10.3.8.3. Product benchmarking
      • 10.3.8.4. Strategic initiatives
    • 10.3.9. Biogenesis Bago
      • 10.3.9.1. Company overview
      • 10.3.9.2. Financial performance
      • 10.3.9.3. Product benchmarking
      • 10.3.9.4. Strategic initiatives
    • 10.3.10. Vetoquinol SA
      • 10.3.10.1. Company overview
      • 10.3.10.2. Financial performance
      • 10.3.10.3. Product benchmarking
      • 10.3.10.4. Strategic initiatives
  • 10.4. Strategic Initiatives
  • 10.5. List of other Key players

List of Tables

  • Table 1 List Of Secondary Sources
  • Table 2 Companion Animal Cardiac Drugs Market, By Region, 2021 - 2033 (USD Million)
  • Table 3 Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 4 Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 5 Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 6 Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 7 Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 8 North America Companion Animal Cardiac Drugs Market, By Country, 2021 - 2033 (USD Million)
  • Table 9 North America Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 10 North America Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 11 North America Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 12 North America Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 13 North America Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 14 U.S. Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 15 U.S. Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 16 U.S. Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 17 U.S. Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 18 U.S. Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 19 Canada Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 20 Canada Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 21 Canada Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 22 Canada Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 23 Canada Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 24 Mexico Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 25 Mexico Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 26 Mexico Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 27 Mexico Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 28 Mexico Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 29 Europe Companion Animal Cardiac Drugs Market, By Country, 2021 - 2033 (USD Million)
  • Table 30 Europe Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 31 Europe Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 32 Europe Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 33 Europe Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 34 Europe Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 35 Germany Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 36 Germany Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 37 Germany Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 38 Germany Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 39 Germany Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 40 UK Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 41 UK Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 42 UK Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 43 UK Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 44 UK Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 45 France Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 46 France Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 47 France Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 48 France Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 49 France Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 50 Italy Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 51 Italy Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 52 Italy Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 53 Italy Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 54 Italy Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 55 Spain Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 56 Spain Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 57 Spain Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 58 Spain Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 59 Spain Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 60 Denmark Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 61 Denmark Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 62 Denmark Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 63 Denmark Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 64 Denmark Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 65 Sweden Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 66 Sweden Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 67 Sweden Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 68 Sweden Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 69 Sweden Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 70 Norway Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 71 Norway Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 72 Norway Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 73 Norway Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 74 Norway Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 75 Asia Pacific Companion Animal Cardiac Drugs Market, By Country, 2021 - 2033 (USD Million)
  • Table 76 Asia Pacific Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 77 Asia Pacific Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 78 Asia Pacific Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 79 Asia Pacific Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 80 Asia Pacific Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 81 China Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 82 China Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 83 China Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 84 China Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 85 China Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 86 Japan Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 87 Japan Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 88 Japan Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 89 Japan Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 90 Japan Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 91 India Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 92 India Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 93 India Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 94 India Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 95 India Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 96 South Korea Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 97 South Korea Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 98 South Korea Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 99 South Korea Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 100 South Korea Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 101 Australia Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 102 Australia Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 103 Australia Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 104 Australia Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 105 Australia Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 106 Thailand Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 107 Thailand Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 108 Thailand Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 109 Thailand Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 110 Thailand Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 111 Latin America Companion Animal Cardiac Drugs Market, By Country, 2021 - 2033 (USD Million)
  • Table 112 Latin America Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 113 Latin America Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 114 Latin America Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 115 Latin America Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 116 Latin America Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 117 Brazil Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 118 Brazil Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 119 Brazil Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 120 Brazil Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 121 Brazil Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 122 Argentina Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 123 Argentina Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 124 Argentina Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 125 Argentina Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 126 Argentina Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 127 MEA Companion Animal Cardiac Drugs Market, By Country, 2021 - 2033 (USD Million)
  • Table 128 MEA Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 129 MEA Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 130 MEA Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 131 MEA Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 132 MEA Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 133 South Africa Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 134 South Africa Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 135 South Africa Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 136 South Africa Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 137 South Africa Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 138 Saudi Arabia Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 139 Saudi Arabia Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 140 Saudi Arabia Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 141 Saudi Arabia Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 142 Saudi Arabia Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 143 UAE Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 144 UAE Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 145 UAE Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 146 UAE Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 147 UAE Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 148 Kuwait Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 149 Kuwait Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 150 Kuwait Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 151 Kuwait Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 152 Kuwait Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 153 Qatar Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 154 Qatar Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 155 Qatar Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 156 Qatar Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 157 Qatar Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 158 Oman Companion Animal Cardiac Drugs Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 159 Oman Companion Animal Cardiac Drugs Market, By Product, 2021 - 2033 (USD Million)
  • Table 160 Oman Companion Animal Cardiac Drugs Market, By Indication, 2021 - 2033 (USD Million)
  • Table 161 Oman Companion Animal Cardiac Drugs Market, By End Use, 2021 - 2033 (USD Million)
  • Table 162 Oman Companion Animal Cardiac Drugs Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 163 Company Overview
  • Table 164 Product Benchmarking
  • Table 165 Financial Performance
  • Table 166 Strategic Initiatives

List of Figures

  • Fig. 1 Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Information Procurement
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value Chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modelling For Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 Companion Animal Cardiac Drugs Market Revenue, 2021 - 2033 (USD Million)
  • Fig. 10 Companion Animal Cardiac Drugs Market Snapshot
  • Fig. 11 Companion Animal Cardiac Drugs Market Driver Impact
  • Fig. 12 Companion Animal Cardiac Drugs Market Restraint Impact
  • Fig. 13 Companion Animal Cardiac Drugs Animal Type Key Takeaways (USD Million)
  • Fig. 14 Companion Animal Cardiac Drugs Market: Animal Type, Market Share 2024 & 2033
  • Fig. 15 Dogs Market, 2021 - 2033 (USD Million)
  • Fig. 16 Cats Market, 2021 - 2033 (USD Million)
  • Fig. 17 Horses Market, 2021 - 2033 (USD Million)
  • Fig. 18 Others Market, 2021 - 2033 (USD Million)
  • Fig. 19 Companion Animal Cardiac Drugs Product Key Takeaways (USD Million)
  • Fig. 20 Companion Animal Cardiac Drugs Market: Product, Market Share 2024 & 2033
  • Fig. 21 Pimobendan Market, 2021 - 2033 (USD Million)
  • Fig. 22 Spironolactone And Benazepril Hydrochloride Market, 2021 - 2033 (USD Million)
  • Fig. 23 Furosemide Market, 2021 - 2033 (USD Million)
  • Fig. 24 Others Market, 2021 - 2033 (USD Million)
  • Fig. 25 Companion Animal Cardiac Drugs Indication Key Takeaways (USD Million)
  • Fig. 26 Companion Animal Cardiac Drugs Market: Indication, Market Share 2024 & 2033
  • Fig. 27 Congestive Heart Failure Market, 2021 - 2033 (USD Million)
  • Fig. 28 Myocardial (Heart Muscle) Disease Market, 2021 - 2033 (USD Million)
  • Fig. 29 Arrhythmias Market, 2021 - 2033 (USD Million)
  • Fig. 30 Others Market, 2021 - 2033 (USD Million)
  • Fig. 31 Companion Animal Cardiac Drugs End Use Key Takeaways (USD Million)
  • Fig. 32 Companion Animal Cardiac Drugs Market: End Use, Market Share 2024 & 2033
  • Fig. 33 Veterinary Hospitals & Clinics Market, 2021 - 2033 (USD Million)
  • Fig. 34 Others Market, 2021 - 2033 (USD Million)
  • Fig. 35 Companion Animal Cardiac Drugs Market By Distribution Channel: Key Takeaways
  • Fig. 36 Companion Animal Cardiac Drugs Market By Distribution Channel, Market Share, 2024 & 2033
  • Fig. 37 Hospital/ Clinic Pharmacy Market, 2021 - 2033 (USD Million)
  • Fig. 38 Retail Market, 2021 - 2033 (USD Million)
  • Fig. 39 E-Commerce Market, 2021 - 2033 (USD Million)
  • Fig. 40 Regional Market Place: Key Takeaways
  • Fig. 41 Regional Outlook, 2024 & 2033
  • Fig. 42 North America Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 43 U.S. Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 44 Canada Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 45 Mexico Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 46 Europe Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 47 UK Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 48 Germany Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 49 France Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 50 Italy Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 51 Spain Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 52 Denmark Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 53 Sweden Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 54 Norway Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 55 Asia Pacific Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 56 Japan Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 57 China Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 58 India Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 59 Australia Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 60 South Korea Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 61 Thailand Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 62 Latin America Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 63 Brazil Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 64 Argentina Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 65 MEA Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 66 South Africa Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 67 Saudi Arabia Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 68 UAE Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 69 Kuwait Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 70 Qatar Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 71 Oman Companion Animal Cardiac Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 72 Market Participant Categorization